Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
Luisa L. Villa(Ludwig Cancer Research), Ronaldo Lúcio Rangel Costa(Instituto Brasileiro de Controle do Câncer), Carlos Alberto Petta(Universidade Estadual de Campinas (UNICAMP)), Rosíres Pereira de Andrade(Centro de Reprodução Humana Prof. Franco Junior), Kevin A. Ault(University of Iowa), Anna R. Giuliano(University of Arizona Cancer Center), Cosette M. Wheeler(University of New Mexico), Laura A. Koutsky(University of Washington), Christian Malm(Institute for Molecular Medicine Finland), Matti Lehtinen(Institute for Molecular Medicine Finland), Finn Egil Skjeldestad(SINTEF), Sven-Eric Olsson(Karolinska Institutet), Margareta Steinwall, Darron R. Brown(Indiana University School of Medicine), Robert J. Kurman(Johns Hopkins University), Brigitte M. Ronnett(Johns Hopkins Medicine), Mark H. Stoler(University of Virginia), Alex Ferenczy(Jewish General Hospital), Diane M. Harper(Dartmouth College), Gretchen Tamms(United States Military Academy), Jimmy Yu(United States Military Academy), Lisa Lupinacci(United States Military Academy), Radha Railkar(United States Military Academy), Frank J. Taddeo(United States Military Academy), Kathrin U. Jansen(United States Military Academy), Mark T. Esser(United States Military Academy), Heather L. Sings(United States Military Academy), Alfred J. Saah(United States Military Academy), Eliav Barr(United States Military Academy)
Cited by 1,579
Abstract
Related Papers
No related papers found
Powered by citation graph analysis